Detalhe da pesquisa
1.
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
Breast Cancer Res
; 26(1): 23, 2024 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317231
2.
Molecular cancer prevention: Current status and future directions.
CA Cancer J Clin
; 65(5): 345-83, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284997
3.
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
Gut
; 70(3): 555-566, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641470
4.
Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
Breast Cancer Res
; 26(1): 53, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532428
5.
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
Br J Cancer
; 120(12): 1105-1112, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097774
6.
Molecularly targeted therapies for p53-mutant cancers.
Cell Mol Life Sci
; 74(22): 4171-4187, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643165
7.
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Breast Cancer Res Treat
; 158(3): 441-54, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27393618
8.
Prevention and early detection of prostate cancer.
Lancet Oncol
; 15(11): e484-92, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25281467
9.
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Breast Cancer Res Treat
; 146(1): 211-20, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839032
10.
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.
Breast Cancer Res Treat
; 147(3): 473-85, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25178514
11.
IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy.
Clin Cancer Res
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578278
12.
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
NPJ Breast Cancer
; 10(1): 7, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238336
13.
Targeting nuclear hormone receptors for the prevention of breast cancer.
Front Med (Lausanne)
; 10: 1200947, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37583424
14.
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.
Cancer Prev Res (Phila)
; 16(1): 47-55, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228112
15.
Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa.
Front Immunol
; 14: 1162669, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207208
16.
Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor.
Cancer Prev Res (Phila)
; 16(1): 17-28, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162136
17.
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
Cancer Prev Res (Phila)
; 16(6): 333-341, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259799
18.
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 9(5): 664-672, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951827
19.
CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
Cancer Res
; 83(7): 1111-1127, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720042
20.
Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.
Mol Pharmacol
; 81(2): 228-38, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22053058